| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 0.83 Billion |
| Market Size (2030) | USD 1.05 Billion |
| CAGR (2025 - 2030) | 4.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Global Thoracic Drainage Devices Market Analysis
The Global Thoracic Drainage Devices Market size is estimated at USD 0.83 billion in 2025, and is expected to reach USD 1.05 billion by 2030, at a CAGR of 4.90% during the forecast period (2025-2030).
Thoracic drainage devices are designed to remove air, liquids, and some solids from the pleural space of the chest. Factors such as rising incidence of lung diseases, such as pneumonia, chronic obstructive pulmonary disease (COPD), and lung cancer has increased the demand for effective thoracic interventions. Additionally, increasing prevalence of trauma-related injuries, particular those involving chest, growing awareness of thoracic-related health issues, regulatory approvals, favourable reimbursement policies, and advancements in thoracic drainage devices are factors driving the growth of the market.
According to the data published by the United Nations International Children's Emergency Fund (UNICEF) in November 2023, globally, there are over 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year, with the greatest incidence occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000 children). Additionally, according to the data published by the Lung Cancer Research Foundation 2023, around 238,340 people has been diagnosed with lung cancer in 2023 in the United States. Thoracic drainage devices, also known as chest tubes, are used in surgeries for lung cancer and pneumonia treatment. These devices are placed in the pleural space after surgery to drain fluid, blood, or air. The increase in lung cancer and pneumonia cases worldwide will drive the need for managing and treating these conditions, boosting the thoracic drainage devices market.
Furthermore, the expansion of clinical trials is set to play a pivotal role in propelling the thoracic drainage devices market. These trials not only spur innovation but also validate new applications and boost the overall efficiency of these devices. For instance, in September 2024, Bearpac Medical, LLC launched clinical trial for Assessing Experience, Safety, and Outcomes of the Passio Pump Drainage System – (AESOP). AESOP is a single center, crossover, non-blinded 1:1 randomised controlled trial, recruiting at North Bristol NHS Trust. The trial's primary focus is on the safety, efficacy, and tolerability of the Passio Pump Drainage System, especially when compared to the BD PleurX Pleural Catheter System. Additionally, the secondary aim is to gauge the overall patient experience with the Passio Pump Drainage System. As these clinical trials gain momentum worldwide, they are poised to significantly influence the future trajectory of thoracic drainage devices, thus driving market expansion.
Therefore, owing to the aforementioned factors such as the growing prevalence of pneumonia and lung cancer, coupled with the growing clinical trials, the studied market is anticipated to witness growth over the analysis period. However, the high cost of thoracic drainage devices and stringent regulatory guidelines may hinder the growth of the market over the forecast period.
Global Thoracic Drainage Devices Market Trends
Thoracic Surgery & Pulmonology Segment is Expected to Register a Significant Growth in the Forecast Years
The thoracic surgery & pulmonology application segment are pivotal in driving the thoracic drainage devices market owing to the prevalence of respiratory diseases, such as pneumonia, lung cancer, and chronic obstructive pulmonary disease (COPD). According to the data published by the Australian Institute of Health and Welfare in June 2024, COPD accounted for 3.6% of the total disease burden and 50% of the total burden of disease due to respiratory conditions in 2023 in Australia. Thus, high burden of COPD creates increased demand for effective thoracic interventions, thereby influencing market growth.
Moreover, advancements in minimally invasive surgical techniques have made thoracic surgeries increasingly prevalent, driving up the demand for dependable drainage devices. For instance, an article published in Frontiers in Surgery in March 2023 highlighted that video-assisted thoracoscopic surgery (VATS), compared to traditional thoracotomy, is less invasive and is now a global standard for diagnosing and treating various chest cavity conditions. The push for less invasive surgeries, aimed at minimizing chest surgery trauma and preserving lung volume, has spurred the evolution of robotic-assisted thoracic surgery (RATS) and uniportal VATS. These advancements highlight the benefits of minimally invasive techniques, fostering their adoption and contributing to market growth.
Furthermore, according to the article published in the Journal of Thoracic Disease in May 2024, employing a digital chest drainage system (DCDS) can shorten both the length of stay (LOS) and chest tube duration. This is particularly relevant in today's context of minimally invasive lung resections and enhanced recovery after surgery (ERAS) protocols. Such findings underscore the growing demand for thoracic drainage devices in thoracic surgery, subsequently driving market growth.
Therefore, owing to the aforesaid factors, such as prevalence of COPD and advancement in minimally invasive surgical techniques, the segment is expected to register a significant growth rate during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Dominate the Thoracic Drainage Devices Market
North America is expected to dominate the market owing to factors such as a well-established healthcare infrastructure with advanced medical facilities and a high prevalence of respiratory diseases, including pneumonia, lung cancer, and other chronic pulmonary conditions. In addition, increasing investments in research and development, rising awareness about early diagnosis and intervention for respiratory ailments, and regulatory support and reimbursement policies are projected to boost the market growth in the region.
The high prevalence of respiratory diseases such as lung cancer creates as significant demand for thoracic drainage procedures. For instance, according to the data published by the Canadian Cancer Society 2024, it was projected that 32,100 people were diagnosed with lung cancer in Canada in 2024. Additionally, female lung cancer diagnoses rose to 17,300 in 2024, up from 15,800 in 2023. Lung cancer often leads to complications such as pleural effusion, which is accumulation of fluid in the pleural space. Therefore, the need for effective fluid management results in an increased demand for thoracic drainage devices.
Furthermore, the increasing focus on research and development (R&D) in the field of thoracic drainage is projected to drive significant growth in the thoracic drainage devices market. For instnace, in September 2024, Bearpac Medical, LLC launched the Assessing Experience, Safety and Outcomes of the Passio Pump Drainage System (AESOP) clinical trial to evaluate the Passio Pump Drainage System, a new thoracic drainage device in the United States. By comparing its effectiveness against a standard catheter, the trial aims to generate valuable clinical data that could enhance the adoption of the Passio system. Successful outcomes may drive innovation and growth within the thoracic drainage devices market, as healthcare providers seek improved safety and efficacy in patient care. This initiative could also foster greater competition and advancements in technology, further enhancing market dynamics.
Moreover, product launches play a crucial role in driving the thoracic drainage devices market by introducing innovative technologies and enhancing treatment options available to healthcare professionals. For instance, in Sepember 2024, Baxter International Inc. introduced its next-generation airway clearance system, The Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference, aimed at improving therapy for patients with chronic lung conditions. By enhancing comfort and incorporating patient-focused features, the system addresses unmet needs in airway management, potentially increasing patient adherence to treatment. Such strategic product introductions boost adoption rates in hospitals and clinics, fueling market growth during the forecast period.
In summary, the increasing prevalence of lung cancer, increasing focus on research and development (R&D) in the field of thoracic drainage, and product launches are likely to increase the demand for thoracic drainage devices in North America and drive the market's growth during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
Global Thoracic Drainage Devices Industry Overview
The thoracic draininage devices market is moderately competitive and consists of a few major players. The major players in the thoracic drainage devices market include ATMOS MedizinTechnik GmbH & Co. KG, Becton, Dickinson and Company, Cardinal Health, Cook, Getinge AB, Sinapi Biomedical, Smiths Group plc, Teleflex Incorporated, Utah Medical Products, Inc. and Vygon SA. To ensure sustainable growth in the sector, these leading companies primarily rely on strategies such as launching new products, engaging in mergers and acquisitions, and forming partnerships and collaborations.
Global Thoracic Drainage Devices Market Leaders
-
Becton Dickinson and Company
-
Cardinal Health
-
Getinge AB
-
Smith Group plc
-
Cook
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Global Thoracic Drainage Devices Market News
- July 2024: Teleflex Incorporated completed a new tower, marking a significant enhancement in its production capacity for precision medical devices, including thoracic drainage devices. This strategic expansion enables the company to scale output and address the growing demand driven by advancements in medical technology across key specialties such as cardiology, neurology, and radiology.
- December 2023: Bearpac Medical, LLC received FDA 510(k) clearance for its Passio Pump Drainage System, extending its application to include the treatment of malignant ascites alongside recurrent pleural effusions. This regulatory approval not only broadens the product's market potential but also reflects the increasing demand for advanced thoracic drainage solutions.
Global Thoracic Drainage Devices Industry Segmentation
As per the scope of the report, thoracic drainage devices are used to drain air, fluid, or blood from the thoracic space to prevent the lungs from collapsing. These devices are primarily used for disease indications such as pneumothorax, cardiac surgery procedures, and pleural effusion. The thoracic drainage devices market is segmented by product, application, end-user, and geography. By product, the market is segmented into thoracic drainage systems, thoracic drainage kits, pleural drainage catheters, trocar drains, and others. The others segment is further bifurcated into secured needle and unsecured needle. By application, the market is segmented into cardiac surgery, oncology & pain management, thoracic surgery & pulmonology, general intensive care emergency medicine and others. The others segment is further bifurcated into infectious diseases and military/damage control/disaster medicine. By end-user, the market is segmented into hospitals & clinics, ambulatory surgery centers, and others. The others segment is further bifurcated into research institutes and academic centers and pulmonology clinics. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product | Thoracic Drainage Systems | ||
| Thoracic Drainage Kits | |||
| Pleural Drainage Catheters | |||
| Trocar Drains | |||
| Other Products ( Secured Needle and Unsecured Needle) | |||
| By Application | Cardiac Surgery | ||
| Oncology & Pain Management | |||
| Thoracic Surgery & Pulmonology | |||
| General Intensive Care Emergency Medicine | |||
| Other Applications (Infectious Diseases and Military/Damage Control/Disaster Medicine) | |||
| By End-User | Hospitals & Clinics | ||
| Ambulatory Surgery Centers | |||
| Others (Research Institutes and Academic Centers and Pulmonology Clinics) | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Rest of the World | |||
Need A Different Region or Segment?
Customize Now
Global Thoracic Drainage Devices Market Research FAQs
How big is the Global Thoracic Drainage Devices Market?
The Global Thoracic Drainage Devices Market size is expected to reach USD 0.83 billion in 2025 and grow at a CAGR of 4.90% to reach USD 1.05 billion by 2030.
What is the current Global Thoracic Drainage Devices Market size?
In 2025, the Global Thoracic Drainage Devices Market size is expected to reach USD 0.83 billion.
Who are the key players in Global Thoracic Drainage Devices Market?
Becton Dickinson and Company, Cardinal Health, Getinge AB, Smith Group plc and Cook are the major companies operating in the Global Thoracic Drainage Devices Market.
Which is the fastest growing region in Global Thoracic Drainage Devices Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Global Thoracic Drainage Devices Market?
In 2025, the North America accounts for the largest market share in Global Thoracic Drainage Devices Market.
What years does this Global Thoracic Drainage Devices Market cover, and what was the market size in 2024?
In 2024, the Global Thoracic Drainage Devices Market size was estimated at USD 0.79 billion. The report covers the Global Thoracic Drainage Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Thoracic Drainage Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
